Medscape HIV/AIDS Podcast

Dr Paul Sax reports on a new recommended HIV treatment option and thanks Marty Hirsch for his skillful leadership of the guidelines working group.

Dr Paul Sax reports on an intriguing two-drug regimen that could become the standard of care in preventing TB.

Dr Paul Sax highlights the findings of the SWORD study of dolutegravir-rilpivirine and outlines the clinical implications.

Increased routine and targeted HIV testing is needed to reduce diagnosis delays.

A large population-based study argues for more rigorous efforts to vaccinate against HPV infection and prevent subsequent head and neck cancers, says Dr Markman.

The latest surveillance report reveals that sexually transmitted infections are again on the rise.

A recently approved shingles vaccine seems to be more effective in preventing the virus. Drs Rapuano and Meghpara from Wills Eye Hospital discuss its role for patients.

Controversy spurred by comments from Georgia state representative Dr Betty Price on HIV is addressed by Dr Paul Sax.

Dr Paul Sax discusses very early antiretroviral therapy in two cases presented at IAS 2017, in which one patient remains in remission and the other does not.

The high burden of HIV among Hispanic and Latino men can be addressed by first making testing a standard of care.